Form D · Other Technology
MDx Medical, Inc. - NJ
Lyndhurst, NJ · CIK 0001511851
Offering snapshot reported Jun 24, 2013 · SEC filing
- Reported sold
- $19.6M Offering amount: $19.6M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 24, 2013 | Initial | $19,607,536 | No comparison | 12 | SEC filing |
| Oct 21, 2011 | Initial | $3,000,000 | No comparison | 11 | SEC filing |
| Feb 3, 2011 | Initial | $16,319,837 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-198455
Series C Preferred Stock
Source: Form D, filed Jun 24, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Boake | Director |
| Richard Forman | Director |
| Brandon Hull | Director |
| Sandra Panem | Director |
| Todd Petri | Director |
| Todd Pietri | Director |
| Mitchel Rothschild | Director, Executive |
| William Sullivan | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
210 Clay Avenue
Lyndhurst, NJ, 07071
Lyndhurst, NJ, 07071